DENALI THERAPEUTICS INC

Ticker: DNLI CUSIP: 24823R105 Class: Common Stock

Rockefeller Capital Management L.P.'s Holding History (CIK: 0001739439)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,265 Value ($000) $21 Avg Close $16.88 Range $13.75 - $20.61
Q3 2025
Shares 1,083 Value ($000) $16 Avg Close $14.37 Range $12.58 - $16.20
Q2 2023
Shares 8,888 Value ($000) $262 Avg Close $28.12 Range $22.72 - $33.31
Q1 2023
Shares 8,724 Value ($000) $0 Avg Close $27.52 Range $21.74 - $32.81
Q4 2022
Shares 9,858 Value ($000) $0 Avg Close $29.75 Range $25.96 - $34.78
Q3 2022
Shares 11,834 Value ($000) $362 Avg Close $32.51 Range $25.88 - $39.43
Q2 2022
Shares 11,230 Value ($000) $330 Avg Close $26.20 Range $20.24 - $35.62
Q1 2022
Shares 19,652 Value ($000) $631 Avg Close $34.41 Range $28.76 - $47.47
Q4 2021
Shares 16,458 Value ($000) $733 Avg Close $47.38 Range $41.10 - $56.08
Q3 2021
Shares 14,799 Value ($000) $745 Avg Close $56.36 Range $47.02 - $79.50
Q2 2021
Shares 7,207 Value ($000) $564 Avg Close $61.86 Range $49.20 - $79.70
Q1 2021
Shares 4,390 Value ($000) $249 Avg Close $66.94 Range $52.23 - $84.25
Q4 2020
Shares 2,500 Value ($000) $209 Avg Close $60.45 Range $35.89 - $93.94
Q3 2020
Shares 2,500 Value ($000) $89 Avg Close $30.12 Range $22.36 - $39.22